HomeCompareSNCE vs NOBL

SNCE vs NOBL: Dividend Comparison 2026

SNCE yields 34.78% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNCE wins by $150.9K in total portfolio value
10 years
SNCE
SNCE
● Live price
34.78%
Share price
$5.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$26,108.19
Full SNCE calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — SNCE vs NOBL

📍 SNCE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNCENOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNCE + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNCE pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNCE
Annual income on $10K today (after 15% tax)
$2,956.52/yr
After 10yr DRIP, annual income (after tax)
$22,191.96/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, SNCE beats the other by $21,979.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNCE + NOBL for your $10,000?

SNCE: 50%NOBL: 50%
100% NOBL50/50100% SNCE
Portfolio after 10yr
$98.3K
Annual income
$13,178.99/yr
Blended yield
13.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SNCE right now

SNCE
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
-3.2
Piotroski
4/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNCE buys
0
NOBL buys
0
No recent congressional trades found for SNCE or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNCENOBL
Forward yield34.78%2.17%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$173.8K$22.9K
Annual income after 10y$26,108.19$249.78
Total dividends collected$125.1K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SNCE vs NOBL ($10,000, DRIP)

YearSNCE PortfolioSNCE Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$14,178$3,478.26$10,917$217.08+$3.3KSNCE
2$19,780$4,608.94$11,903$221.48+$7.9KSNCE
3$27,173$6,009.16$12,962$225.68+$14.2KSNCE
4$36,791$7,715.34$14,099$229.68+$22.7KSNCE
5$49,129$9,762.64$15,319$233.49+$33.8KSNCE
6$64,752$12,183.73$16,628$237.10+$48.1KSNCE
7$84,292$15,007.57$18,033$240.53+$66.3KSNCE
8$108,451$18,258.34$19,539$243.78+$88.9KSNCE
9$137,997$21,954.52$21,154$246.86+$116.8KSNCE
10$173,765$26,108.19$22,884$249.78+$150.9KSNCE

SNCE vs NOBL: Complete Analysis 2026

SNCEStock

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Full SNCE Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this SNCE vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNCE vs SCHDSNCE vs JEPISNCE vs OSNCE vs KOSNCE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.